Unknown

Dataset Information

0

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

ABSTRACT: There is evidence that progesterone plays a role in the aetiology of invasive epithelial ovarian cancer. Therefore, genes involved in pathways that regulate progesterone may be candidates for susceptibility to this disease. Previous studies have suggested that genetic variants in the progesterone receptor gene (PGR) may be associated with ovarian cancer risk, although results have been inconsistent. We have established an international consortium to pool resources and data from many ovarian cancer case-control studies in an effort to identify variants that influence risk. In this study, three PGR single nucleotide polymorphisms (SNPs), for which previous data have suggested they affect ovarian cancer risk, were examined. These were +331 C/T (rs10895068), PROGINS (rs1042838), and a 3' variant (rs608995). A total of 4788 ovarian cancer cases and 7614 controls from 12 case-control studies were included in this analysis. Unconditional logistic regression was used to model the association between each SNP and ovarian cancer risk and two-sided P-values are reported. Overall, risk of ovarian cancer was not associated with any of the three variants studied. However, in histopathological subtype analyses, we found a statistically significant association between risk of endometrioid ovarian cancer and the PROGINS allele (n=651, OR=1.17, 95% CI=1.01-1.36, P=0.036). We also observed borderline evidence of an association between risk of endometrioid ovarian cancer and the +331C/T variant (n=725 cases; OR=0.80, 95% CI 0.62-1.04, P=0.100). These data suggest that while these three variants in the PGR are not associated with ovarian cancer overall, the PROGINS variant may play a modest role in risk of endometrioid ovarian cancer.

SUBMITTER: Pearce CL 

PROVIDER: S-EPMC2361465 | biostudies-literature | 2008 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

Pearce C L CL   Wu A H AH   Gayther S A SA   Bale A E AE   Beck P A PA   Beesley J J   Chanock S S   Cramer D W DW   DiCioccio R R   Edwards R R   Fredericksen Z S ZS   Garcia-Closas M M   Goode E L EL   Green A C AC   Hartmann L C LC   Hogdall E E   Kjaer S K SK   Lissowska J J   McGuire V V   Modugno F F   Moysich K K   Ness R B RB   Ramus S J SJ   Risch H A HA   Sellers T A TA   Song H H   Stram D O DO   Terry K L KL   Webb P M PM   Whiteman D C DC   Whittemore A S AS   Zheng W W   Pharoah P D P PD   Chenevix-Trench G G   Pike M C MC   Schildkraut J J   Berchuck A A  

British journal of cancer 20080122 2

There is evidence that progesterone plays a role in the aetiology of invasive epithelial ovarian cancer. Therefore, genes involved in pathways that regulate progesterone may be candidates for susceptibility to this disease. Previous studies have suggested that genetic variants in the progesterone receptor gene (PGR) may be associated with ovarian cancer risk, although results have been inconsistent. We have established an international consortium to pool resources and data from many ovarian canc  ...[more]

Similar Datasets

Unknown Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.
| S-EPMC3108970 | biostudies-literature
Unknown Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.
| S-EPMC2972411 | biostudies-literature
Unknown Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.
| S-EPMC5593071 | biostudies-literature
Unknown ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
| S-EPMC2863004 | biostudies-literature
Unknown Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.
| S-EPMC8026532 | biostudies-literature
Unknown Genetic variation in the progesterone receptor gene and ovarian cancer risk.
| S-EPMC1380205 | biostudies-literature
Unknown The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.
| S-EPMC4426869 | biostudies-literature
Unknown Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
| S-EPMC5418444 | biostudies-literature
Unknown Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
| S-EPMC4931371 | biostudies-literature
Unknown Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
| S-EPMC4063682 | biostudies-literature